Imagin Medical Inc. IMEXF
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -41.89% | -30.57% | -19.59% | -18.37% | -- |
| Depreciation & Amortization | 407.95% | 288.70% | 172.57% | 57.76% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.05% | -23.59% | -10.51% | -0.41% | -- |
| Operating Income | 36.05% | 23.59% | 10.51% | 0.41% | -- |
| Income Before Tax | 46.38% | 93.50% | 91.43% | 79.17% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.38% | 93.50% | 91.43% | 79.17% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.38% | 93.50% | 91.43% | 79.17% | -- |
| EBIT | 36.05% | 23.59% | 10.51% | 0.41% | -- |
| EBITDA | 39.74% | 26.18% | 12.04% | 0.91% | -- |
| EPS Basic | 53.97% | 95.90% | 93.40% | 81.98% | -- |
| Normalized Basic EPS | 114.56% | 128.37% | 123.04% | 114.39% | -- |
| EPS Diluted | 53.97% | 95.90% | 93.40% | 81.98% | -- |
| Normalized Diluted EPS | 114.56% | 128.37% | 123.04% | 114.39% | -- |
| Average Basic Shares Outstanding | 10.70% | 11.19% | 11.81% | 10.54% | -- |
| Average Diluted Shares Outstanding | 10.70% | 11.19% | 11.81% | 10.54% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |